Literature DB >> 17309405

Ten years of highly active antiretroviral therapy for HIV infection.

Luke F Chen1, Jennifer Hoy, Sharon R Lewin.   

Abstract

Over the past 10 years, the management of HIV infection has been transformed by an increased number of effective antiretrovirals (ARVs), with more convenient dosing and improved tolerability. Optimal management of HIV infection includes at least three effective ARVs; from at least two different drug classes. Current strategies and drugs can effectively control HIV and significantly reduce morbidity and mortality. However, no cure is yet possible. Appropriate use of ARVs leads to suppression of virological replication (to below the limit of detection using commercial assays to measure HIV in plasma) and an increase in CD4(+) T cells with few adverse effects. Greater than 95% adherence to drug therapy is required for effective viral suppression and immunological improvement. Monotherapy, two-drug combinations, sequential ARVs, drug "cycling", and treatment interruptions are ineffective management strategies and lead to earlier disease progression and emergence of drug resistance. Drug-drug interactions are common and caution is required when prescribing ARVs that inhibit or induce the cytochrome P450 pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309405     DOI: 10.5694/j.1326-5377.2007.tb00839.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  28 in total

1.  Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration.

Authors:  Supachai Sakkhachornphop; Carlos F Barbas; Rassamee Keawvichit; Kanlaya Wongworapat; Chatchai Tayapiwatana
Journal:  Hum Gene Ther       Date:  2012-05-08       Impact factor: 5.695

Review 2.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

3.  The role of jails in engaging PLWHA in care: from jail to community.

Authors:  Richard C Rapp; Rachel Ciomcia; Nick Zaller; Jeff Draine; Ann Ferguson; Robin Cagey
Journal:  AIDS Behav       Date:  2013-10

4.  Is the US AIDS drug assistance program cost-effective?

Authors:  Steven D Pinkerton; Jennifer Kibicho; Carol L Galletly
Journal:  AIDS Behav       Date:  2013-01

Review 5.  Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action.

Authors:  Caroline Bazzoli; Vincent Jullien; Clotilde Le Tiec; Elisabeth Rey; France Mentré; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

Review 6.  Fracture management in HIV positive individuals: a systematic review.

Authors:  Maheshi P C Wijesekera; Simon Matthew Graham; David Griffith Lalloo; Hamish Simpson; William J Harrison
Journal:  Int Orthop       Date:  2016-09-21       Impact factor: 3.075

Review 7.  Virus maturation as a new HIV-1 therapeutic target.

Authors:  Catherine S Adamson; Karl Salzwedel; Eric O Freed
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

8.  Disorder in clotting pattern after antiretroviral treatment with emtricitabine in an HIV-positive haemophiliac patient.

Authors:  Antonio Liras
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

9.  Life priorities in the HIV-positive Asians: a text-mining analysis in young vs. old generation.

Authors:  Wei-Ti Chen; Russell Barbour
Journal:  AIDS Care       Date:  2016-08-12

10.  A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization.

Authors:  Fiona Young; Julia A Critchley; Lucy K Johnstone; Nigel C Unwin
Journal:  Global Health       Date:  2009-09-14       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.